MCNAMARA KEVIN J — SEC insider filings

SEC reporting owner CIK 1207137. 57 insider filings on record with FilingPulse; latest filed 2026-11-05.

Transaction summary — filings shown

Covers the 50 most recent of 57 filings on record, filed 2021-05-06 to 2026-11-05. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.

By issuer — same filings

Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.

IssuerRole (as filed)FilingsPurchases (P)Sales (S)Other legs
CHEMED CORP (CHE)president and CEO, Director50—37 legs · 93,000 sh · $47,326,55077

Insider filings — MCNAMARA KEVIN J

FiledFormIssuerReported transactionsSource
2026-11-054CHEMED CORP (CHE)Sale (S): 2,000 @ $537.90EDGAR
2026-10-224CHEMED CORP (CHE)Grant/award (A): 36,693 (derivative) @ $512.64EDGAR
2026-09-304CHEMED CORP (CHE)Sale (S): 2,000 @ $513.45EDGAR
2026-09-214CHEMED CORP (CHE)Sale (S): 2,000 @ $501.40EDGAR
2026-08-244CHEMED CORP (CHE)Sale (S): 2,000 @ $541.16EDGAR
2026-08-044CHEMED CORP (CHE)Option exercise (M): 2,001 @ $445.35 · Tax withholding (F): 19,802 @ $529.22 · Sale (S): 2,000 @ $539.51 · Option exercise (M): 2,001 (derivative) @ $445.35EDGAR
2026-05-044CHEMED CORP (CHE)Sale (S): 2,000 @ $421.13EDGAR
2026-03-304CHEMED CORP (CHE)Sale (S): 1,500 @ $369.37EDGAR
2026-03-134CHEMED CORP (CHE)Sale (S): 2,000 @ $403.18EDGAR
2026-02-174CHEMED CORP (CHE)Option exercise (M): 2,714 @ $469.56 · Option exercise (M): 0 @ $469.56 · Tax withholding (F): 1,192 @ $469.56 · Option exercise (M): 2,187 (derivative) @ $0 · Option exercise (M): 2,187 (derivative) @ $0 · Grant/award (A): 5,114 (derivative) @ $0EDGAR
2025-11-254CHEMED CORP (CHE)Sale (S): 2,000 @ $437.55EDGAR
2025-10-224CHEMED CORP (CHE)Grant/award (A): 58,672 (derivative) @ $443.79EDGAR
2025-09-294CHEMED CORP (CHE)Sale (S): 3,000 @ $461.28EDGAR
2025-08-054CHEMED CORP (CHE)Sale (S): 2,000 @ $428.55EDGAR
2025-05-064CHEMED CORP (CHE)Option exercise (M): 10,000 @ $471.74 · Tax withholding (F): 8,982 @ $574.02 · Sale (S): 1,500 @ $576.45 · Option exercise (M): 10,000 (derivative) @ $471.74EDGAR
2025-04-014CHEMED CORP (CHE)Sale (S): 1,000 @ $615.33EDGAR
2025-03-074CHEMED CORP (CHE)Sale (S): 2,000 @ $593.67EDGAR
2025-02-184CHEMED CORP (CHE)Option exercise (M): 4,086 @ $553.39 · Option exercise (M): 1,235 @ $553.39 · Tax withholding (F): 2,377 @ $553.39 · Option exercise (M): 2,023 (derivative) @ $0 · Option exercise (M): 2,023 (derivative) @ $0 · Grant/award (A): 4,372 (derivative) @ $0EDGAR
2024-11-264CHEMED CORP (CHE)Sale (S): 2,000 @ $572.77EDGAR
2024-10-234CHEMED CORP (CHE)Grant/award (A): 40,332 (derivative) @ $597.70EDGAR
2024-09-274CHEMED CORP (CHE)Sale (S): 2,000 @ $598.81EDGAR
2024-08-064CHEMED CORP (CHE)Option exercise (M): 5,000 @ $445.35 · Tax withholding (F): 4,314 @ $586.14 · Sale (S): 2,000 @ $569.63 · Option exercise (M): 5,000 (derivative) @ $445.35EDGAR
2024-06-074CHEMED CORP (CHE)Sale (S): 1,500 @ $544.17EDGAR
2024-05-174CHEMED CORP (CHE)Sale (S): 4,000 @ $567.54EDGAR
2024-02-204CHEMED CORP (CHE)Option exercise (M): 1,081 @ $586.49 · Option exercise (M): 1,623 @ $586.49 · Tax withholding (F): 1,208 @ $586.49 · Option exercise (M): 1,737 (derivative) @ $0 · Option exercise (M): 1,737 (derivative) @ $0 · Grant/award (A): 3,770 (derivative) @ $0EDGAR
2023-12-134CHEMED CORP (CHE)Sale (S): 1,500 @ $572.77EDGAR
2023-11-014CHEMED CORP (CHE)Option exercise (M): 5,700 @ $413.19 · Option exercise (M): 10,000 @ $445.35 · Tax withholding (F): 13,647 @ $562.32 · Sale (S): 5,000 @ $560.68 · Option exercise (M): 5,700 (derivative) @ $413.19 · Option exercise (M): 10,000 (derivative) @ $445.35EDGAR
2023-10-264CHEMED CORP (CHE)Grant/award (A): 37,756 (derivative) @ $509.46EDGAR
2023-08-074CHEMED CORP (CHE)Sale (S): 4,000 @ $516.43 · Option exercise (M): 3,000 @ $413.19 · Tax withholding (F): 2,656 @ $516.79 · Option exercise (M): 3,000 (derivative) @ $413.19EDGAR
2023-05-084CHEMED CORP (CHE)Sale (S): 4,000 @ $549.34EDGAR
2023-05-034CHEMED CORP (CHE)Option exercise (M): 31,500 @ $413.19 · Tax withholding (F): 27,040 @ $549.27 · Option exercise (M): 31,500 (derivative) @ $413.19EDGAR
2023-05-024CHEMED CORP (CHE)Option exercise (M): 3,500 @ $413.19 · Tax withholding (F): 3,002 @ $550.48 · Option exercise (M): 3,500 (derivative) @ $413.19EDGAR
2023-03-294CHEMED CORP (CHE)Sale (S): 3,000 @ $526.27EDGAR
2023-03-104CHEMED CORP (CHE)Sale (S): 2,000 @ $507.32EDGAR
2023-02-224CHEMED CORP (CHE)Option exercise (M): 2,705 @ $515.12 · Option exercise (M): 1,540 @ $515.12 · Tax withholding (F): 1,896 @ $515.12 · Option exercise (M): 1,339 (derivative) @ $0 · Option exercise (M): 1,339 (derivative) @ $0 · Grant/award (A): 4,374 (derivative) @ $0EDGAR
2022-11-224CHEMED CORP (CHE)Sale (S): 2,000 @ $505.76EDGAR
2022-11-044CHEMED CORP (CHE)Sale (S): 2,000 @ $482.90 · Tax withholding (F): 3,971 @ $479.27 · Option exercise (M): 5,000 @ $306.70 · Option exercise (M): 5,000 (derivative) @ $306.70EDGAR
2022-11-024CHEMED CORP (CHE)Grant/award (A): 35,772 (derivative) @ $462.04EDGAR
2022-09-144CHEMED CORP (CHE)Sale (S): 2,000 @ $474.13EDGAR
2022-08-224CHEMED CORP (CHE)Sale (S): 3,000 @ $481.93 · Option exercise (M): 5,000 @ $306.70 · Tax withholding (F): 3,950 @ $484.94 · Option exercise (M): 5,000 (derivative) @ $306.70EDGAR
2022-05-114CHEMED CORP (CHE)Sale (S): 2,000 @ $502EDGAR
2022-05-044CHEMED CORP (CHE)Sale (S): 3,000 @ $486.79 · Option exercise (M): 10,000 @ $306.70 · Tax withholding (F): 7,863 @ $489.91 · Option exercise (M): 10,000 (derivative) @ $306.70EDGAR
2022-03-094CHEMED CORP (CHE)Option exercise (M): 10,000 @ $306.70 · Tax withholding (F): 7,973 @ $475.22 · Sale (S): 3,000 @ $469.91 · Option exercise (M): 10,000 (derivative) @ $306.70EDGAR
2022-02-234CHEMED CORP (CHE)Option exercise (M): 4,977 @ $459.77 · Option exercise (M): 3,243 @ $459.77 · Tax withholding (F): 3,671 @ $459.77 · Option exercise (M): 2,464 (derivative) @ $0 · Option exercise (M): 2,464 (derivative) @ $0 · Grant/award (A): 4,046 (derivative) @ $0EDGAR
2021-11-164CHEMED CORP (CHE)Sale (S): 3,000 @ $500.54EDGAR
2021-11-034CHEMED CORP (CHE)Option exercise (M): 26,000 @ $231.91 · Tax withholding (F): 18,216 @ $487.06 · Sale (S): 6,000 @ $485.06 · Option exercise (M): 26,000 (derivative) @ $231.91EDGAR
2021-11-024CHEMED CORP (CHE)Grant/award (A): 36,803 (derivative) @ $445.35EDGAR
2021-08-104CHEMED CORP (CHE)Sale (S): 3,000 @ $467.78EDGAR
2021-06-074CHEMED CORP (CHE)Sale (S): 3,000 @ $497.61EDGAR
2021-05-064CHEMED CORP (CHE)Option exercise (M): 4,000 @ $231.91 · Tax withholding (F): 2,809 @ $484.12 · Sale (S): 3,000 @ $477.37 · Option exercise (M): 4,000 (derivative) @ $231.91EDGAR

FilingPulse's Form 4 archive currently extends back to 2020-08-06 and is expanding backward through EDGAR history; Forms 3 and 5 are covered live-forward since 2026-09-23 (no 3/5 history). Earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.

Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1207137 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. Get a free API key → · API docs